Annual ROE
-81.91%
-2.67%-3.37%
December 31, 2023
Summary
- As of February 12, 2025, IOVA annual return on equity is -81.91%, with the most recent change of -2.67% (-3.37%) on December 31, 2023.
- During the last 3 years, IOVA annual ROE has fallen by -42.37% (-107.16%).
- IOVA annual ROE is now -140.74% below its all-time high of 201.04%, reached on December 31, 2011.
Performance
IOVA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-58.90%
+8.09%+12.08%
September 30, 2024
Summary
- As of February 12, 2025, IOVA quarterly return on equity is -58.90%, with the most recent change of +8.09% (+12.08%) on September 30, 2024.
- Over the past year, IOVA quarterly ROE has increased by +11.71% (+16.58%).
- IOVA quarterly ROE is now -100.18% below its all-time high of 32.72 thousand%, reached on June 30, 2011.
Performance
IOVA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
IOVA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.4% | +16.6% |
| 3 y3 years | -107.2% | +8.3% |
| 5 y5 years | -209.0% | +8.3% |
IOVA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.8% | at low | -16.7% | +28.7% |
| 5 y | 5-year | -107.2% | at low | -53.9% | +28.7% |
| alltime | all time | -140.7% | +96.7% | -100.2% | +96.2% |
Iovance Biotherapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -58.90%(-12.1%) |
| Jun 2024 | - | -66.99%(-5.1%) |
| Mar 2024 | - | -70.61%(-0.5%) |
| Dec 2023 | -81.91%(+3.4%) | -70.93%(-0.9%) |
| Sep 2023 | - | -71.59%(-8.6%) |
| Jun 2023 | - | -78.33%(-3.3%) |
| Mar 2023 | - | -81.00%(-1.9%) |
| Dec 2022 | -79.24%(+43.9%) | -82.56%(+8.0%) |
| Sep 2022 | - | -76.45%(+19.0%) |
| Jun 2022 | - | -64.22%(+17.2%) |
| Mar 2022 | - | -54.79%(+8.5%) |
| Dec 2021 | -55.05%(+39.2%) | -50.48%(+11.3%) |
| Sep 2021 | - | -45.34%(+10.3%) |
| Jun 2021 | - | -41.12%(+7.4%) |
| Mar 2021 | - | -38.27%(-12.6%) |
| Dec 2020 | -39.54%(-40.2%) | -43.81%(-13.5%) |
| Sep 2020 | - | -50.64%(-14.7%) |
| Jun 2020 | - | -59.35%(-16.5%) |
| Mar 2020 | - | -71.12%(+33.8%) |
| Dec 2019 | -66.08%(+149.3%) | -53.16%(+31.9%) |
| Sep 2019 | - | -40.29%(+3.6%) |
| Jun 2019 | - | -38.88%(+3.4%) |
| Mar 2019 | - | -37.60%(-2.4%) |
| Dec 2018 | -26.51%(-58.1%) | -38.51%(-20.7%) |
| Sep 2018 | - | -48.55%(+0.9%) |
| Jun 2018 | - | -48.13%(-10.0%) |
| Mar 2018 | - | -53.45%(-14.4%) |
| Dec 2017 | -63.28%(+99.7%) | -62.42%(+16.5%) |
| Sep 2017 | - | -53.58%(+6.6%) |
| Jun 2017 | - | -50.24%(+29.0%) |
| Mar 2017 | - | -38.95%(+16.7%) |
| Dec 2016 | -31.69% | -33.38%(+4.6%) |
| Sep 2016 | - | -31.92%(+16.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | -27.48%(-0.1%) |
| Mar 2016 | - | -27.51%(+8.9%) |
| Dec 2015 | -26.59%(-0.9%) | -25.27%(-1.0%) |
| Sep 2015 | - | -25.53%(-5.7%) |
| Jun 2015 | - | -27.08%(-14.7%) |
| Mar 2015 | - | -31.73%(-37.3%) |
| Dec 2014 | -26.84%(-81.4%) | -50.57%(-54.0%) |
| Sep 2014 | - | -109.88%(-47.3%) |
| Jun 2014 | - | -208.68%(-44.5%) |
| Mar 2014 | - | -375.93%(-102.9%) |
| Dec 2013 | -144.19%(-593.5%) | 12.91 K%(+9100.5%) |
| Sep 2013 | - | 140.27%(+794.6%) |
| Jun 2013 | - | 15.68%(-257.0%) |
| Mar 2013 | - | -9.99%(-146.6%) |
| Dec 2012 | 29.22%(-85.5%) | 21.42%(-77.6%) |
| Sep 2012 | - | 95.67%(-38.2%) |
| Jun 2012 | - | 154.89%(-53.5%) |
| Mar 2012 | - | 332.88%(-36.1%) |
| Dec 2011 | 201.04%(-179.8%) | 521.27%(-54.6%) |
| Sep 2011 | - | 1148.69%(-96.5%) |
| Jun 2011 | - | 32.72 K%(-6563.4%) |
| Mar 2011 | - | -506.16%(+57.8%) |
| Dec 2010 | -252.00%(-315.3%) | -320.75%(+25.0%) |
| Sep 2010 | - | -256.60%(+263.0%) |
| Jun 2010 | - | -70.69%(+7.9%) |
| Mar 2010 | - | -65.52%(-138.2%) |
| Dec 2009 | 117.04%(-104.7%) | 171.58%(-67.8%) |
| Sep 2009 | - | 532.69%(-134.4%) |
| Jun 2009 | - | -1547.83%(+239.6%) |
| Mar 2009 | - | -455.79%(+43.9%) |
| Dec 2008 | -2482.61% | -316.78%(+72.2%) |
| Sep 2008 | - | -183.95%(+21.4%) |
| Jun 2008 | - | -151.50%(+104.2%) |
| Mar 2008 | - | -74.19% |
FAQ
- What is Iovance Biotherapeutics annual return on equity?
- What is the all time high annual ROE for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual ROE year-on-year change?
- What is Iovance Biotherapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly ROE year-on-year change?
What is Iovance Biotherapeutics annual return on equity?
The current annual ROE of IOVA is -81.91%
What is the all time high annual ROE for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual return on equity is 201.04%
What is Iovance Biotherapeutics annual ROE year-on-year change?
Over the past year, IOVA annual return on equity has changed by -2.67% (-3.37%)
What is Iovance Biotherapeutics quarterly return on equity?
The current quarterly ROE of IOVA is -58.90%
What is the all time high quarterly ROE for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly return on equity is 32.72 K%
What is Iovance Biotherapeutics quarterly ROE year-on-year change?
Over the past year, IOVA quarterly return on equity has changed by +11.71% (+16.58%)